Mackenzie Financial Corp Abbott Laboratories Transaction History

Mackenzie Financial Corp

$63.2 Billion
Q2 2024

A detailed history of Mackenzie Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Mackenzie Financial Corp holds 1,329,644 shares of ABT stock, worth $149 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,329,644

Previous 1,099,544 20.93%

Holding current value

$149 Million

Previous $125 Million 10.55%

% of portfolio

0.22%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $23.2 Million - $25.9 Million	230,100 Added 20.93%	1,329,644 $138 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $38.9 Million - $42.9 Million	-354,763 Reduced 24.39%	1,099,544 $125 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $7.18 Million - $8.79 Million	-79,652 Reduced 5.19%	1,454,307 $160 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $964,184 - $1.16 Million	-10,093 Reduced 0.65%	1,533,959 $149 Million
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $33.7 Million - $37.6 Million	334,571 Added 27.66%	1,544,052 $168 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $211,251 - $248,655	-2,181 Reduced 0.18%	1,209,481 $122 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $16.1 Million - $18.8 Million	168,921 Added 16.2%	1,211,662 $133 Million
Q3 2022 Oct 07, 2022	BUY	$96.76 - $112.03 $11.2 Million - $12.9 Million	115,446 Added 12.45%	1,042,741 $101 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $11.6 Million - $14.1 Million	114,042 Added 14.02%	927,295 $101 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.77 Million - $2.16 Million	15,521 Added 1.95%	813,253 $96.3 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $47.5 Million - $58.1 Million	-410,742 Reduced 33.99%	797,732 $112 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $56.7 Million - $62.7 Million	-486,118 Reduced 28.69%	1,208,474 $143 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $8.1 Million - $9.53 Million	76,565 Added 4.73%	1,694,592 $196 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $8.75 Million - $10.3 Million	80,388 Added 5.23%	1,618,027 $194 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $8.39 Million - $9.14 Million	-79,872 Reduced 4.94%	1,537,639 $168 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $2.55 Million - $3.1 Million	27,817 Added 1.75%	1,617,511 $176 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $5.99 Million - $7.67 Million	78,263 Added 5.18%	1,589,694 $145 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $92 Million - $135 Million	1,464,498 Added 3120.4%	1,511,431 $119 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $1.15 Million - $1.28 Million	14,589 Added 45.11%	46,933 $4.08 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $588,184 - $637,774	7,187 Added 28.57%	32,344 $2.71 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $60,490 - $70,550	-830 Reduced 3.19%	25,157 $2.12 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $319,445 - $386,209	4,824 Added 22.79%	25,987 $2.08 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $75,131 - $85,113	-1,146 Reduced 5.14%	21,163 $1.53 Million
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $170,024 - $205,114	-2,796 Reduced 11.14%	22,309 $1.64 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $350,889 - $387,276	6,095 Added 32.06%	25,105 $1.53 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $99,766 - $112,798	1,773 Added 10.29%	19,010 $1.14 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $25,927 - $27,758	483 Added 2.88%	17,237 $984,000
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $140,575 - $156,897	-2,925 Reduced 14.86%	16,754 $894,000
Q2 2017 Aug 14, 2017	BUY	N/A	19,679	19,679 $957,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Abbott Laboratories Transaction History